Core Insights - Orogen Royalties Inc. reported record total revenue of CAD 13.1 million for the year ended December 31, 2025, representing a 32% increase from CAD 9.9 million in 2024 [1][3] - The company achieved a preliminary pre-tax net income of CAD 7.0 million for 2025, up 63% from CAD 4.3 million in 2024, and an after-tax net income of CAD 4.1 million, up 58% from CAD 2.6 million in 2024 [1][2] Financial Performance - For Q4 2025, Orogen earned CAD 6.3 million in total revenue, a 50% increase from CAD 4.3 million in Q4 2024 and a 259% increase from Q3 2025 [2] - The Ermitaño royalty revenue for Q4 2025 was CAD 3.1 million, a 29% increase from CAD 2.4 million in Q4 2024, while Prospect Generation revenue also increased by 94% to CAD 3.1 million from CAD 1.6 million in the same quarter of 2024 [2] Strategic Outlook - The company emphasizes its strategy of organic royalty creation and acquisitions, with a focus on the Ermitaño mine, which is expected to generate significant royalty revenues in 2026 [3][4] - Orogen holds a 2% net smelter return royalty on the Ermitaño mine, with estimated royalty revenues projected between CAD 7.1 million (USD 5.1 million) and CAD 10.3 million (USD 7.5 million) based on anticipated production and commodity prices [4] Operational Highlights - As of December 31, 2025, Orogen had working capital of CAD 25.8 million and no debt, positioning the company for continued growth [2] - The company’s exploration team is actively pursuing self-funded and alliance-based opportunities, aiming to expand its royalty portfolio [3]

Summary of XOMA Corporation Conference Call Company Overview - **Company**: XOMA Corporation (NasdaqGM:XOMA) - **Industry**: Biotechnology - **Key Leadership**: CEO Owen Hughes, CFO Jeff Trigilio, Chief Investment Officer Brad Sitko Core Points and Arguments - **Portfolio Strategy**: XOMA aims to increase optionality within its portfolio, focusing on building a robust pipeline to withstand the binary nature of biotech. The company has 15 assets in phase 3 development, with 2 recent failures attributed to a higher-than-expected placebo effect. Despite this, the company's valuation remains stable, indicating confidence in its portfolio's potential [6][7]. - **Asset Growth**: Over the past three years, XOMA has added approximately 80 assets while reducing its share count, demonstrating effective capital management and a strategy to leverage future returns without diluting equity [8]. - **Tremfya Economics**: XOMA has a claim related to the commercialization of Tremfya, which it believes is integral to the drug's development. Although a recent arbitration was unsuccessful, the company sees potential in pursuing Johnson & Johnson for royalties, with a market cap of $450-$500 million and significant potential financial upside if successful [9][12][14]. - **Litigation Outlook**: The company is optimistic about the potential for a settlement or favorable ruling in its ongoing litigation, which could provide additional funding for business development and shareholder returns [19][22][27]. - **Takeda Transaction**: In 2025, XOMA completed a significant transaction with Takeda, exchanging one asset for nine additional assets, enhancing its portfolio and optionality. This deal is part of a broader strategy to diversify risk and increase net present value (NPV) [34][35]. Financial Highlights - **2025 Financial Performance**: XOMA reported over $50 million in top-line revenue, with $33 million from royalty receipts. The company achieved free cash flow positivity and repurchased $16 million of stock, indicating strong financial health [42][43]. - **Future Projections**: The company anticipates continued growth in royalties from approved therapies, with expectations of covering operational expenses and financial obligations through royalties alone by 2027. XOMA has over $620 million in net operating losses (NOLs) and capitalized R&D deductions, allowing it to maintain a low effective tax rate [51][52]. Upcoming Catalysts - **Clinical Trials**: XOMA has several upcoming catalysts, including the phase 2b readout for volixibat and a phase 3 trial for ersodetug, both of which could significantly impact the company's financials and market position [79][85]. - **Vabysmo Royalties**: Currently generating approximately $25 million annually from Vabysmo royalties, with expectations for continued growth. The drug's performance will influence the company's ability to pay off loans and return cash flows to shareholders [89][90]. Additional Insights - **Business Model**: XOMA's strategy focuses on acquiring non-dilutive capital and building a diversified portfolio to mitigate risks associated with biotech investments. The company emphasizes the importance of maintaining a flat share count while pursuing growth opportunities [60][64]. - **Market Positioning**: The company recognizes the challenges in biotech, including the unpredictability of clinical success and market dynamics. XOMA aims to leverage its unique assets and partnerships to create sustainable revenue streams [55][56]. This summary encapsulates the key points discussed during the conference call, highlighting XOMA's strategic direction, financial performance, and future opportunities within the biotechnology sector.

NASDAQ COMMON: XOMA NASDAQ PERPETUAL PREFERRED SHARES: XOMAP, XOMAO THE ROYALTY AGGREGATOR FOR BIOTECH COMPANIES Q1 2026 CORPORATE PRESENTATION XOMA ROYALTY – WHAT WE DO Royalties Milestones Science Structuring DISCLAIMERS Certain statements in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding: future potential monetization opportunities, active transactions w ...

Evolve Royalties Conference Call Summary Company Overview - **Company Name**: Evolve Royalties - **Ticker**: EVR (CSE) - **Business Model**: Focused on providing capital to strategic element and base metal mines through innovative royalty and stream contracts [1][4] Core Industry Insights - **Industry Focus**: Mining sector, specifically copper and other base metals - **Market Dynamics**: Increasing geopolitical focus on securing critical minerals, with copper being central to this discussion [5][11] - **Copper Price Outlook**: Anticipated upside in copper prices over the next few years, which will open financing opportunities for new projects [6][10] Business Model and Strategy - **Royalty Model**: Evolve invests directly in mines by acquiring royalties, which provide a percentage of revenues perpetually without the need for further capital [6][7] - **Portfolio Composition**: Currently holds 14 assets, with 11 being royalties, primarily focused on copper [12][13] - **Geopolitical Risk Profile**: The portfolio is characterized by high-quality jurisdictions and well-capitalized operators [13][14] Key Assets - **Highland Valley Copper**: Largest copper mine in Canada, producing nearly 130,000 tons of copper last year, with a mine life extension program extending operations until 2046 [18][19] - **McIlvenna Bay**: A new copper project in Saskatchewan, currently under construction, with significant resource growth potential [19][20] - **Copper Mountain**: A significant open-pit mine in British Columbia, expected to start generating royalty payments later this year [22][23] - **Lithium Asset**: A royalty on a lithium brine project in Argentina, with a potential cash flow of approximately CAD 10 million once production begins [24][25] Financial Overview - **Market Capitalization**: CAD 150 million as of the latest share price [27] - **Cash and Investments**: Approximately CAD 40 million [27] - **Acquisition Strategy**: Focus on cash-flowing royalties to enhance capital structure and facilitate future acquisitions [28][29] Growth Catalysts - **Upcoming Projects**: Anticipated cash flow from new mines coming online in 2026 and construction of the lithium project [26][41] - **Institutional Investor Interest**: Over 40% institutional ownership, which is crucial for future capital raising [29][30] - **Market Positioning**: Aiming to grow from a CAD 100 million to a CAD 1 billion market cap through strategic acquisitions and portfolio growth [30][31] Differentiation and Competitive Advantage - **Unique Focus**: Unlike many royalty companies that focus on precious metals, Evolve targets base metals and battery metals, particularly copper [38][39] - **Experienced Team**: The management team has a strong background in the royalty business, enhancing their ability to identify and capitalize on opportunities [38] Long-term Vision - **Success Metrics**: Management holds 15% of the company, emphasizing alignment with shareholder interests and a focus on profitable growth [43] Conclusion - **Market Outlook**: Evolve Royalties is positioned to capitalize on the growing demand for copper and other critical minerals, with a strong portfolio and a clear strategy for growth in the mining sector [31][34]

Group 1 - Texas Pacific Land Corp. (TPL) has entered into a strategic partnership with Bolt Data & Energy to develop large-scale data center campuses, contributing one-third of the $150 million capital raised for the project [3][4] - The data center campuses are expected to start with a capacity of 1 gigawatt (GW) and aim for a total capacity of 10 GW, with potential tenants including major tech companies like Google, Microsoft, and Amazon [4][5] - TPL's investment in this project positions it as a cornerstone investor in the AI data center market, highlighting the growing demand for AI processing capabilities [3][4] Group 2 - The Texas data center market is rapidly expanding, with several projects announced, including Project Matador by Fermi America with a planned capacity of 11 GW and Bolt's project with 10 GW [12] - Existing data centers are becoming technologically obsolete, creating additional demand for new facilities that can meet the evolving power and cooling requirements of advanced AI chips [13][16] - The rapid advancement in chip technology, particularly from NVIDIA, is driving the need for data centers that can handle increased power consumption and cooling demands [10][18] Group 3 - The water demand for data centers and power plants is significant, with a large-scale data center potentially requiring around 67 million barrels of water annually, which is more than the water needed for the associated power plant [92][93] - TPL's water resources are becoming increasingly valuable, with water revenues exceeding 35% of total revenues in 2024, reflecting a strong growth trajectory [101][104] - The company operates a capital-light business model, focusing on source water and saltwater disposal, which positions it favorably in the expanding data center ecosystem [102][104]

Summary of EMX Royalty and Elemental Altus Royalty Merger Conference Call Companies Involved - **EMX Royalty Corporation** - **Elemental Altus Royalty** Core Points and Arguments Merger Announcement - The merger between Elemental Altus Royalty and EMX Royalty Corporation is a significant event in the royalty space, especially as gold prices reach new all-time highs [2][3][4] Value of Royalties - The value of mineral rights has historically increased, with gold prices rising from $35 to $3,500 per ounce over 50 years, indicating a compounded annual growth rate (CAGR) of approximately 8-9% [3] - Royalties provide exposure to mineral rights with embedded optionality, making scale crucial in the royalty business [3][4] Portfolio Strength - The combined portfolio will feature cornerstone royalties from key assets such as Caserones, Timok, Cactus, and Laverton, which are expected to enhance the company's position in the market [7][8][16] - The merger will create a portfolio of approximately 200 royalties, with many in pre-production stages, indicating significant future value [26][27] Financial Performance - EMX Royalty Corporation has achieved a 17% CAGR over 22.5 years, while Elemental Altus has surpassed 20% CAGR over eight years, showcasing strong historical performance [9][10] - The combined entity is projected to generate $70 to $80 million in revenue going forward, with 45% of the net asset value from cash-flowing assets and 55% from growth potential [21][18] Cost Synergies and Efficiency - The merger is expected to yield multiple millions in cost savings, with a focus on efficiency and value creation rather than just cost-cutting [22][24] - The increased scale will improve the companies' trading relative to their net asset value (PNAV), which is currently at one times PNAV, one of the lowest in the junior royalty space [24][26] Shareholder Support and Future Plans - Tether's involvement as a cornerstone shareholder is seen as a significant catalyst for growth and capital availability [6][75] - The companies plan to pursue a U.S. listing to enhance liquidity and attract more investors, qualifying for various indices that could drive capital flows [42][43] Management and Governance - The combined board will include experienced members from both companies, with a focus on maintaining a strong governance structure [34][35] - The management team is expected to leverage their combined expertise in prospect generation and royalty acquisition to drive future growth [31][32] Dividend Potential - The combined entity is in a strong position to consider dividends in the future, balancing shareholder returns with growth opportunities [68][69] Market Context - The merger announcement coincides with a peak in gold prices, positioning the new entity favorably in a bullish market environment [77] Other Important Content - The merger is framed as a strategic move to create a "dream team" in the royalty space, combining strengths in both royalty generation and acquisition [75] - The companies emphasize the importance of maintaining a disciplined approach to capital allocation and investment in high-quality assets [80][81] This summary encapsulates the key points discussed during the conference call regarding the merger between EMX Royalty Corporation and Elemental Altus Royalty, highlighting the strategic rationale, financial implications, and future outlook for the combined entity.

Core Insights - EMX Royalty Corporation reported strong financial results for the first half of 2025, with significant increases in adjusted royalty revenue and adjusted EBITDA, leading to an increase in 2025 revenue guidance due to rising commodity prices [1][2][7] Financial Performance - For the six months ended June 30, 2025, EMX achieved revenue and other income of $14.7 million, adjusted royalty revenue of $19.0 million, and adjusted EBITDA of $12.1 million [1][20] - In Q2 2025, the company recognized adjusted revenue and other income of $8.7 million, a 1% decrease from Q2 2024, while adjusted royalty revenue increased by 5% to $8.2 million [17][20] - Cash flows from operating activities for the first half of 2025 were $8.2 million, compared to $0.5 million in the same period of 2024, marking a significant improvement [5][34] Updated Guidance - EMX has updated its 2025 guidance, projecting GEO sales to range from 10,500 to 12,000 and adjusted royalty revenue between $30 million and $35 million, up from the previous guidance of $26 million to $32 million [7][8] Capital Management - The company made a $10 million early repayment towards its credit facility, reducing the principal from $35 million to $25 million [9] - EMX executed a new Normal-Course Issuer Bid program, allowing for the repurchase of up to 5,440,027 common shares, with 1,202,168 shares repurchased during the quarter [9][10] Portfolio Growth - Key growth drivers include producing assets at Caserones in Chile and Timok in Serbia, with ongoing exploration programs aimed at expanding mineral resources [12][16] - The acquisition of a royalty on the Chapi Copper Mine in Peru is expected to contribute to revenue starting in 2026 [13] Operational Highlights - The company reported a 20% decrease in operating expenditures compared to 2024, primarily due to reduced generative expenditures [10] - EMX's financial position remains strong, with cash and cash equivalents of $17.2 million and working capital of $30.2 million as of June 30, 2025 [5][9]